| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/1997 | WO1997013511A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 04/17/1997 | WO1997013510A1 Treatment of migraine |
| 04/17/1997 | WO1997013509A1 Vascular permeation inhibitor |
| 04/17/1997 | WO1997013508A1 Topical liquid composition, method for preparing same and uses thereof |
| 04/17/1997 | WO1997013507A1 Use of creatine analogues for the treatment of disorders of glucose metabolism |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | WO1997013505A2 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 04/17/1997 | WO1997013504A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 04/17/1997 | WO1997013502A2 Prolonged release of gm-csf |
| 04/17/1997 | WO1997013501A1 Liposomal compositions and methods of using them |
| 04/17/1997 | WO1997013500A2 LIPOSOME FORMULATIONS OF 5β STEROIDS |
| 04/17/1997 | WO1997013499A1 Liposomal formulations of mitoxantrone |
| 04/17/1997 | WO1997013495A1 Antimicrobial compositions containing a c3-c6 alcohol |
| 04/17/1997 | WO1997013489A2 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 04/17/1997 | WO1997013415A1 Therapeutic diet for dogs with lymphoma |
| 04/17/1997 | WO1997005870A3 Use of griseofulvin for inhibiting the growth of cancers |
| 04/17/1997 | WO1997005864A3 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs |
| 04/17/1997 | WO1997005862A3 Use of basic amino acids and derivatives for lowering ceramide levels |
| 04/17/1997 | WO1997004783A3 Bis-1-oxaquinolizidine alkaloids from a marine sponge with antitumor activity |
| 04/17/1997 | WO1997003701A3 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 04/17/1997 | DE19545139C1 Use of 1-hydroxy-pyridone cpds. to control yeast and fungi |
| 04/17/1997 | DE19538402A1 Lipidalkohole als neue immunsuppressive und antivirale Arzneimittel Lipid alcohols as new immunosuppressive and antiviral drugs |
| 04/17/1997 | DE19538088A1 Phenanthridinderivate und ihre Herstellung Phenanthridine derivatives and their preparation |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | CA2288415A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 04/17/1997 | CA2234666A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | CA2234604A1 Recombinant herpes virus vectors for expression in neuronal cells |
| 04/17/1997 | CA2234560A1 Pyrazolones |
| 04/17/1997 | CA2234511A1 1,3,5-trisubstituted pyrazoles for treatment of inflammation |
| 04/17/1997 | CA2234484A1 Novel amine derivatives of epipodophyllotoxin 2", 3"-dideoxyglycosides, preparation method therefor and use thereof as a drug and for treating cancer |
| 04/17/1997 | CA2234404A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 04/17/1997 | CA2234401A1 Vascular permeation inhibitor |
| 04/17/1997 | CA2234267A1 Lipophilic benzothiophenes |
| 04/17/1997 | CA2234255A1 Cephalosporin antibiotics |
| 04/17/1997 | CA2234166A1 N-¬2-substituted-3-(2-aminoethyl)-1h-indol-5-yl|-amides: new 5-ht1f agonists |
| 04/17/1997 | CA2234158A1 Treatments of helicobacter pylori infections |
| 04/17/1997 | CA2233673A1 Disubstituted piperidine derivatives |
| 04/17/1997 | CA2233502A1 Pyrimidin derivatives |
| 04/17/1997 | CA2233313A1 Methods to identify modulators of cell signaling |
| 04/17/1997 | CA2232640A1 Antimicrobial compositions containing a c3-c6 alcohol |
| 04/17/1997 | CA2232231A1 Pilosulin 2 |
| 04/17/1997 | CA2232155A1 Improvements in or relating to protection against intracellular infection |
| 04/17/1997 | CA2231647A1 Fast drying, film forming iodine release solution |
| 04/17/1997 | CA2231561A1 Use of a .gamma.-rar-specific agonist ligand to increase apoptosis rate |
| 04/17/1997 | CA2231547A1 Liposomal compositions and methods of using them |
| 04/17/1997 | CA2231273A1 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
| 04/17/1997 | CA2208215A1 Liposome formulations of 5.beta. steroids |
| 04/17/1997 | CA2207243A1 Endothelin receptor antagonists |
| 04/17/1997 | CA2206446A1 Novel polycyclic aminopyridine compounds as acetylcholinesterase inhibitors, preparation process and use thereof |
| 04/17/1997 | CA2187850A1 Physiologically active ei-1941 compounds |
| 04/16/1997 | EP0768375A1 Lactic bacteria |
| 04/16/1997 | EP0768312A2 Bis-Staurosporine and K-252a derivatives |
| 04/16/1997 | EP0768310A1 Process for the production of imidazo-benzodiazepine derivatives |
| 04/16/1997 | EP0768309A1 Process for the preparation of enantiomerically pure imidazolyl compounds |
| 04/16/1997 | EP0768308A1 New derivatives of pyroglutaminic acid, preparation process and applications |
| 04/16/1997 | EP0768307A1 Heterocyclic tertiary amines, process for their preparation and pharmaceutical compositions containing them |
| 04/16/1997 | EP0768306A1 Physiologically active hydrogenated benzopyran compounds |
| 04/16/1997 | EP0768305A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 04/16/1997 | EP0768304A1 N-(Pyrimidinyl)-benzenesulfonamides as medicaments |
| 04/16/1997 | EP0768302A2 Hydroxypyridinones |
| 04/16/1997 | EP0768301A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists |
| 04/16/1997 | EP0768087A2 Treating substance abuse withdrawal |
| 04/16/1997 | EP0768086A1 Treatment of tinnitus using neuroprotective agents |
| 04/16/1997 | EP0768085A1 Antibacterial agent |
| 04/16/1997 | EP0768084A1 Cancerous metastasis inhibitor |
| 04/16/1997 | EP0768083A2 The use of sertraline to treat post myocardial infarction patients |
| 04/16/1997 | EP0768043A2 Diabetic nutritional product having controlled absorption of carbohydrate |
| 04/16/1997 | EP0767842A1 Methods of screening for nucleoside analogs that are incorporated by hiv reverse transcriptase and cause incorrect base pairing |
| 04/16/1997 | EP0767840A2 Method for introducing foreign matter into higher eukaryotic cells |
| 04/16/1997 | EP0767801A1 Endothelin antagonists ii |
| 04/16/1997 | EP0767800A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 04/16/1997 | EP0767798A1 Sterol derivatives used for regulation of meiosis |
| 04/16/1997 | EP0767794A1 Phosphinic acid derivatives |
| 04/16/1997 | EP0767793A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 04/16/1997 | EP0767792A1 Vitronectin receptor antagonists |
| 04/16/1997 | EP0767788A1 New brefeldin a derivatives and their utility in the treatment of cancer |
| 04/16/1997 | EP0767787A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
| 04/16/1997 | EP0767786A1 7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 04/16/1997 | EP0767783A1 Substituted alkyldiamine derivatives and their use as tachykinin antagonists |
| 04/16/1997 | EP0767782A1 Aryl and heteroaryl alkoxynaphthalene derivatives |
| 04/16/1997 | EP0767777A1 New salts of 2- (2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations |
| 04/16/1997 | EP0767773A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same |
| 04/16/1997 | EP0767679A1 Low viscosity chelating polymers |
| 04/16/1997 | EP0767677A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 04/16/1997 | EP0767673A1 Methods for reduced renal uptake of antibody fragments |
| 04/16/1997 | EP0767671A1 Method of combating acyclovir-resistant herpes simplex viral infections |
| 04/16/1997 | EP0767669A1 New pharmaceutical preparation for pain management |
| 04/16/1997 | EP0767667A2 USE OF $g(b)GalNac(1-4)$g(b)Gal CONJUGATES TO TREAT CANDIDA INFECTION |
| 04/16/1997 | EP0767666A1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 04/16/1997 | EP0767665A1 Protective prostaglandins for use in conjunction with chemotherapeutic agents |
| 04/16/1997 | EP0767664A2 Combination therapy for hiv infection |
| 04/16/1997 | EP0767663A1 Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide |
| 04/16/1997 | EP0767662A1 Dopamine d 1? agonists for the treatment of dementia |
| 04/16/1997 | EP0767661A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 04/16/1997 | EP0767660A1 Methods and formulations for modulating the human sexual response |
| 04/16/1997 | EP0767659A1 Transdermal administration of oxybutynin |
| 04/16/1997 | EP0767658A1 Anti-acne cosmetic compositions |
| 04/16/1997 | EP0767657A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 04/16/1997 | EP0767634A1 Microcapsules for administration of neuroactive agents |
| 04/16/1997 | EP0708770B1 Amide derivatives of 16-membered ring antibiotic macrolides |